Purpose This systematic review with network meta-analysis compared the efficacy and safety of currently licensed second-line treatments in patients with late stage non-small cell lung cancer (NSCLC).

NIAID Data Ecosystem50

Single cell RNA sequencing of NSCLC cells from patients' CSF

单细胞RNA测序

非小细胞肺癌

To investigate the genes involved in leptomeningeal (LM) dissemination of non-small cell lung cancer (NSCLC) we captured single cells in cerebrospinal fluid (CSF) of four patients suspected with brain

NIAID Data Ecosystem40

Supplementary Material for: Entrectinib response to ROS1-fusion-positive non-small-cell lung cancer that progressed on crizotinib with leptomeningeal metastasis: A case report

非小细胞肺癌

药物反应

Introduction C-ros oncogene 1 (ROS1) translocation is an oncogenic driver-mutation identified in 1% to 2% of non-small-cell lung cancer (NSCLC) cases. Although crizotinib, a tyrosine kinase inhibitor

DataCite Commons2023-12-12 更新70

Real world data of efficacy of osimertinib in pretreated patients with advanced non-small cell lung cancer harboring EGFR T790M mutation.

非小细胞肺癌

药物疗效

Real world data of efficacy of osimertinib in pretreated patients with advanced non-small cell lung cancer harboring EGFR T790M mutation.

NIAID Data Ecosystem50